Optimizing Timelines: The Impact of Cycle Time Strategy in GMP Analytical Services

Companies developing small molecules and biologics seek to collaborate with labs that provide access to expertise and capabilities for pharmaceutical development. In addition to testing services that meet quality agreements, performance metrics and timelines, our GMP lab provides strategic value that exceeds expectations and creates competitive advantage.

Improving cycle time requires a “right the first time” approach and continuous process improvement. Prioritizing continuous cycle time improvement provides significant mid- and long-term value for clients.

In this white paper, we discuss how our customers can expect reduced release testing cycle time, accelerated biosimilar method development and scaled resources from our GMP lab.